Zhang Y, Pi J, Wang L, Chen J, et al. Dupilumab in Children Under 6 Years With Moderate-to-Severe Atopic Dermatitis: A 16-Week Real-World Prospective Study on Efficacy, Safety, and Local-Systemic Immune Responses. Allergy 2025 Oct 7. doi: 10.1111/all.70090.
PMID: 41055300